Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease: Reversal by Enzyme Replacement Therapy
Circulation - United States
doi 10.1161/hc3801.096352
Full Text
Open PDFAbstract
Available in full text
Date
September 25, 2001
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)